Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL7244192

Cc1ccccc1-c1ccc([N+](=O)[O-])cc1.N

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.51
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
CA9 Q16790 1/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
MAPT P10636 2/20 0.51
CRHBP P24387 1/20 0.51
CRHR2 Q13324 1/20 0.51
HSD17B10 Q99714 2/20 0.50
ACHE P22303 1/20 0.50
CYP19A1 P11511 1/20 0.50
ALDH1A1 P00352 4/20 0.48
LMNA P02545 1/20 0.48
AR P10275 1/20 0.48
NPBWR1 P48145 1/20 0.48
HTR7 P34969 1/20 0.48
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
SCN2A Q99250 1/20 0.46
POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5277109 0.98 CA12 (0.53) CA12CA1CA2CA9SMN1; SMN2
Ammonia Solution, Strong SCHEMBL22130284 0.86 TSHR (0.50) CA12CA9SMN1; SMN2MAPTCRHBP
SCHEMBL28240316 0.82 ALDH1A1 (0.58) CA12CA1CA2CA9MAPT
SCHEMBL2137445 0.81 CYP19A1 (0.54) CA12CA1CA2CA9MAPT
SCHEMBL11348910 0.80 ACHE (0.44) SMN1; SMN2MAPTCRHBPCRHR2HSD17B10
SCHEMBL14154089 0.79 ALDH1A1 (0.62) SMN1; SMN2MAPTHSD17B10ACHEALDH1A1
SCHEMBL18449560 0.79 IDO1 (0.50) SMN1; SMN2MAPTCRHBPCRHR2CYP19A1
SCHEMBL4984806 0.79 KCNH2 (0.54) MAPTCYP19A1ALDH1A1
SCHEMBL30532372 0.79 AKR1C3 (0.57) SMN1; SMN2MAPTACHECYP19A1ALDH1A1
SCHEMBL5849628 0.79 AKR1C3 (0.57) SMN1; SMN2MAPTACHECYP19A1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6552088-B2 2'-methyl-biphenyl-2-carboxylic acid-(3,5-bis-trifluoromethyl-benzyl)-methyl-amide, for example; treating disease related to neurokinin 1 receptor HOFFMANN-LA ROCHE INC. 2003-04-22 US disclosed